drugset / Trial / NCT06421103
Micro-dosing Indocyanine Green (ICG) in Children
NaSingle-groupOpen-labelDiagnostic
Summary
The goal of this cohort study is to identify the lowest dose of Indocyanine Green (ICG) that achieves satisfactory intra-operative fluorescence for the assessment of gastrointestinal or genitourinary tract perfusion in children.
Timeline
- Start
- 2024-06
- Primary completion
- 2028-08
- Completion
- 2028-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Indocyanine Green | Diagnostic / imaging agent | 0.01 mg/kg | Intravenous |
| Subject | Indocyanine Green | Diagnostic / imaging agent | 0.02 mg/kg | Intravenous |
| Subject | Indocyanine Green | Diagnostic / imaging agent | 0.04 mg/kg | Intravenous |
| Subject | Indocyanine Green | Diagnostic / imaging agent | 0.06 mg/kg | Intravenous |
| Subject | Indocyanine Green | Diagnostic / imaging agent | 0.08 mg/kg | Intravenous |